| NCT ID | Title | Status | Phases | Start Date | Completion Date | Primary Completion Date |
|---|---|---|---|---|---|---|
| NCT05444894 | EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT) | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2022-04-29 | 2025-12 | 2025-09 |
| NCT04853576 | A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY) | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2021-05-04 | 2025-08 | 2025-08 |
| NCT03872479 | Single Ascending Dose Study in Participants With LCA10 | UNKNOWN | PHASE1, PHASE2 | 2019-09-26 | 2025-05-23 | 2025-05-23 |